Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020

被引:488
|
作者
Leung, Kathy [1 ,2 ]
Shum, Marcus H. H. [1 ,2 ,3 ,4 ]
Leung, Gabriel M. [1 ,2 ]
Lam, Tommy T. Y. [1 ,2 ,3 ,4 ]
Wu, Joseph T. [1 ,2 ]
机构
[1] Univ Hong Kong, LKS Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, Hong Kong, Peoples R China
[2] Lab Data Discovery Hlth D24H, Hong Kong Sci Pk, Hong Kong, Peoples R China
[3] Univ Hong Kong, Sch Publ Hlth, State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China
[4] Shantou Univ, Joint Inst Virol Shantou Univ & Univ Hong Kong, Guangdong Hongkong Joint Lab Emerging Infect Dis, Shantou, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.2807/1560-7917.ES.2020.26.1.2002106
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Two new SARS-CoV-2 lineages with the N501Y mutation in the receptor-binding domain of the spike protein spread rapidly in the United Kingdom. We estimated that the earlier 501Y lineage without amino acid deletion Delta 69/Delta 70, circulating mainly between early September and mid-November, was 10% (6-13%) more transmissible than the 501N lineage, and the 501Y lineage with amino acid deletion Delta 69/Delta 70, circulating since late September, was 75% (70-80%) more transmissible than the 501N lineage.
引用
收藏
页码:15 / 21
页数:7
相关论文
共 50 条
  • [21] N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
    Tian, Fang
    Tong, Bei
    Sun, Liang
    Shi, Shengchao
    Zheng, Bin
    Wang, Zibin
    Dong, Xianchi
    Zheng, Peng
    ELIFE, 2021, 10
  • [22] The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum
    Lu, Lu
    Chu, Allen Wing-Ho
    Zhang, Ricky Ruiqi
    Chan, Wan-Mui
    Ip, Jonathan Daniel
    Tsoi, Hoi-Wah
    Chen, Lin-lei
    Cai, Jian-Piao
    Lung, David Christopher
    Tam, Anthony Raymond
    Yau, Yat-Sun
    Kwan, Mike Yat-Wah
    To, Wing-Kin
    Tsang, Owen Tak-Yin
    Lee, Larry Lap-Yip
    Yi, Haisu
    Ip, Tak-Chuen
    Poon, Rosana Wing-Shan
    Siu, Gilman Kit-Hang
    Mok, Bobo Wing-Yee
    Cheng, Vincent Chi-Chung
    Chan, Kwok Hung
    Yuen, Kwok-Yung
    Hung, Ivan Fan-Ngai
    Kai-Wang To, Kelvin
    EBIOMEDICINE, 2021, 71
  • [23] SARS-CoV-2 spike protein N501Y mutation causes differential species transmissibility and antibody sensitivity: a molecular dynamics and alchemical free energy study
    Hou, Xudong
    Zhang, Zhilin
    Gao, Jiali
    Wang, Yingjie
    MOLECULAR SYSTEMS DESIGN & ENGINEERING, 2021, 6 (11) : 964 - 974
  • [24] In silico analysis of SARS-CoV-2 spike protein N501Y and N501T mutation effects on human ACE2 binding
    Cubuk, Hasan
    Ozbil, Mehmet
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 116
  • [25] N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding
    Niu, Zubiao
    Zhang, Zhengrong
    Gao, Xiaoyan
    Du, Peng
    Lu, Jingjing
    Yan, Bohua
    Wang, Chenxi
    Zheng, You
    Huang, Hongyan
    Sun, Qiang
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [26] Fast Prediction of Binding Affinities of the SARS-CoV-2 Spike Protein Mutant N501Y (UK Variant) with ACE2 and Miniprotein Drug Candidates
    Williams, Alexander H.
    Zhan, Chang-Guo
    JOURNAL OF PHYSICAL CHEMISTRY B, 2021, 125 (17): : 4330 - 4336
  • [27] SARS-CoV-2 spike evolutionary behaviors; simulation of N501Y mutation outcomes in terms of immunogenicity and structural characteristic
    Rostami, Neda
    Choupani, Edris
    Hernandez, Yaeren
    Arab, Seyed S.
    Jazayeri, Seyed M.
    Gomari, Mohammad M.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (02) : 417 - 430
  • [28] The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence
    Salimovic-Besic, Irma
    Dedeic-Ljubovic, Amela
    Zahirovic, Edina
    Hasanovic, Medina
    Sehic, Merima
    Vukovikj, Maja
    Boshevska, Golubinka
    Vegar-Zubovic, Sandra
    Mehmedika-Suljic, Enra
    Izetbegovic, Sebija
    HELIYON, 2022, 8 (12)
  • [29] Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2
    Zhao, Shi
    Lou, Jingzhi
    Chong, Marc K. C.
    Cao, Lirong
    Zheng, Hong
    Chen, Zigui
    Chan, Renee W. Y.
    Zee, Benny C. Y.
    Chan, Paul K. S.
    Wang, Maggie H.
    VIRUSES-BASEL, 2021, 13 (04):
  • [30] N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding
    Zubiao Niu
    Zhengrong Zhang
    Xiaoyan Gao
    Peng Du
    Jingjing Lu
    Bohua Yan
    Chenxi Wang
    You Zheng
    Hongyan Huang
    Qiang Sun
    Signal Transduction and Targeted Therapy, 6